Abstract:Co-delivery of multiple drugs with complementary anticancer mechanisms by nano-carriers offers an effective strategy to treat cancer. The combination of drugs with pro-apoptotic and anti-angiogenic activities is potentially effective in treating human hepatocellular carcinoma (HCC). Herein, we developed a co-delivery system for doxorubicin (Dox), a pro-apoptotic drug, and curcumin (Cur), a potent drug for antiangiogenesis, in pH-sensitive nanoparticles (NPs) constituted with amphiphilic poly(p-amino ester) copolymer. Dox & Cur co-loaded NPs ((D + C)/NPs) were prepared with optimized drug ratio, showing low polydispersity, high encapsulation efficiency, and enhanced release in the acidic environment of cancer cells. Furthermore, enhanced cellular internalization of cargoes delivered from (D + C)/NPs were observed in human liver cancer SMMC 7721 cells and human umbilical vein endothelial cells (HUVECs) compared to the use of free drugs. The (D + C)/NPs induced a high rate of apoptosis in SMMC 7721 cells through decreased mitochondrial membrane potential. Additionally, (D + C)/NPs exhibited stronger anti-angiogenic effects including inhibition of HUVEC proliferation, migration, invasion, and tube formation mediated VEGF pathway modulation in vitro and in vivo. Taken together, encapsulation of the pro-apoptotic drug Dox and antiangiogenic agent Cur in pH-sensitive NPs provides a promising strategy to effectively inhibit HCC progression in a synergistic manner.Statement of SignificanceThe combination of multiple drugs has been demonstrated to be more effective than single treatment. However, the different physicochemical and pharmacokinetic profiles of each drug render optimal delivery challenging. In view of the great delivery advantage of nanocarriers to unify the multiple drugs in vivo, stimulus-responsive nano-carriers are more crucial to increase efficacy and reduce toxicity from off-target exposure. Therefore, herein the pH-sensitive nanoparticles, composed by D-alpha-tocopheryl polyethylene glycol 1000-block-poly (beta-amino ester) (TPGS-PAE) polymers, have been fabricated for doxorubicin (Dox) and curcumin (Cur) co-delivery, which exhibited diverse anticancer approaches, i.e. proapoptosis and antiangiogenesis. The precise intracellular target site and effective drug combination concentration result in the enhanced antitumor efficiency and the reduced systematic toxicity of Dox. The co-encapsulation of the pro-apoptotic drug and antiangiogenic agent in pH-sensitive NPs provides a promising strategy to effectively inhibit malignant neoplasm progression in a synergistic manner. (C) 2017 Published by Elsevier Ltd on behalf of Acta Materialia Inc.

Codelivery Of Sh-Aspirin And Curcumin By Mpeg-Plga Nanoparticles Enhanced Antitumor Activity By Inducing Mitochondrial Apoptosis

Exploring the Effect of Different Linkers on Self-Assembly, ROS-sensitivity and Anticancer Efficacy of Hydroxyethyl Starch-Curcumin Prodrug

Co-Delivery of Curcumin and Paclitaxel by "Core-Shell" Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer.

Novel Polymeric Hybrid Nanocarrier for Curcumin and Survivin Shrna Co-delivery Augments Tumor Penetration and Promotes Synergistic Tumor Suppression

Improving the Anti-Colon Cancer Activity of Curcumin with Biodegradable Nano-Micelles.

Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo.

Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment

The Anti-Tumor Efficacy of Curcumin when Delivered by Size/charge-Changing Multistage Polymeric Micelles Based on Amphiphilic Poly(β-Amino Ester) Derivates

Amphiphilic Curcumin Conjugate-Forming Nanoparticles As Anticancer Prodrug and Drug Carriers: in Vitro and in Vivo Effects

In vitro/vivo evaluation of novel mitochondrial targeting charge-reversal polysaccharide-based antitumor nanoparticle

Computer Simulation on Polymer Micelles Combined Administration of Gambogic Acid and Curcumin as a Novel Anti-Cancer Drug Carrier

Ph-Sensitive Polymeric Nanoparticles for Co-Delivery of Doxorubicin and Curcumin to Treat Cancer Via Enhanced Pro-Apoptotic and Anti-Angiogenic Activities

Copolymeric Micelles Loading Curcumin: Preparation, Characterization and In Vitro Evaluation.

Improving Antiangiogenesis and Anti-Tumor Activity of Curcumin by Biodegradable Polymeric Micelles.

Codelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancer.

Biodegradable Micelles Enhance The Antiglioma Activity Of Curcumin In Vitro And In Vivo

Curcumin-Loaded Tpgs/F127/P123 Mixed Polymeric Micelles For Cervical Cancer Therapy: Formulation, Characterization, And In Vitro And In Vivo Evaluation

Combined Delivery and Anti-Cancer Activity of Paclitaxel and Curcumin Using Polymeric Micelles.

Co-Delivery of Triptolide and Curcumin for Ovarian Cancer Targeting Therapy via mPEG-DPPE/CaP Nanoparticle.

Synergistically enhanced anticancer effect of codelivered curcumin and siPlk1 by stimuli-responsive α-lactalbumin nanospheres.

Co-Delivery of Curcumin and Chrysin by Polymeric Nanoparticles Inhibit Synergistically Growth and hTERT Gene Expression in Human Colorectal Cancer Cells